This study has demonstrated that OTUD1 is a central regulatory factor in these signal pathways, and the genetic ablation of OTUD1 is associated with inflammatory bowel disease, hepatitis, sepsis, and kidney cancer (Figs. 6, 7 and Supplementary Figs. 6, 7) [16, 28]. This evidence concerns the gene OTUD1 and hepatitis A virus infection.